Status:
COMPLETED
Applications Site Reactions After Injection of Insulin Detemir and Saline in Subjects With Diabetes
Lead Sponsor:
Lise Tarnow
Collaborating Sponsors:
Novo Nordisk A/S
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
To compare application site reactions after superficial and deep subcutaneous and intradermal injections of insulin detemir and saline in patients with diabetes \- The patient serves as his own contr...
Eligibility Criteria
Inclusion
- Diabetes mellitus
- HbA1c\<11 %
- BMI: 20-35 kg/m2
- Insulin detemir naive
- Basal insulin dose\>20E
Exclusion
- Known allergy to study drug
- Current steroid or antiallergic treatment
- Lipodystrophy
- Change in insulin and antihypertensive treatment \< 30 days
- Smokers or alcoholics
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00607737
Start Date
January 1 2008
End Date
July 1 2010
Last Update
September 3 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Steno Diabetes Center
Gentofte Municipality, Denmark, 2820